View Author
virus fluenza patient fluenza virus netherland laboratory assay detection oseltamivir pandemic specimen meijer fluenza viruses rt-pcr study protocol value health resistance result speci 2009. primers therapy probe analysis surveillance m-gene substitution network infection van der vries ic 50 values sequence oseltamivir therapy hospital h 275y disease table panel h 1v assays emergence identi fied cdc primers cdc protocol “ gold method fluenza pandemic susceptibility ct values centre jonge point university contact research immunosuppressed isolation sentinel period swine variant sensitivity center outbreak / journal koopman immunosuppressed patients zanamivir nucleotide triton x -100 81–89 health care worker addition outbreak assistance laboratories h 275y substitution 2010. transmission sequencing pb 2 sequences
2 Most Recent Publications
|
Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010
(Article)
Meijer, A. Jonges, M. Isken, L. Jong, A. de Donker, G.A. Kroes, A. Leenders, S. Lubben, M. van der Mascini, E. Niesters, B. Oosterheert, J.J. Osterhaus, A.D.M.E. Abbink, F. Riesmeijer, R. Riezebos-Brilman, A. Schutten, M. Sebens, F. Stelma, F.F. Swaan, C. Timen, A. Veen, A. van 't Vries, E. van der Wierik, M. te Ang, W. Koopmans, M. Beek, D.J. van der Beersma, M.F.C. Bloembergen, P. Boucher, C.A.B. Claas, E. Gageldonk-Lafeber, R. van |
2011-10-01
|
|
Strengthening the diagnostic capacity to detect Bio Safety Level 3 organisms in unusual respiratory viral outbreaks
(Article)
Asten, L. van Lubben, M. van der Hermans, M. Melchers, W. Rossen, J. Schuurman, R. Wolffs, P. Bouchier, C. Schirm, J. Kroes, L. Leenders, S. Galama, J. Wijngaard, C. van den Peeters, M. Loon, A. van Stobberingh, E. Schutten, M. Koopmans, M.P.G. Pelt, W. van Verheij, R. Jacobi, A. Overduin, P. Meijer, A. Luijt, D. Claas, E. |
2009-07-01
|
